Programme
09H00: Welcome
- 09H30: Institutional partners introduction
- 09H45: Eurobiomed Introduction
- Emilie ROYERE, Executive Director
- 09H55: “Marseille Immunology Biocluster-MIB” project presentation
- Daniel OLIVE, M.D., PhD, University professor, Hospital Practitioner, Aix-Marseille Université, Institut Paoli-Calmettes, Senior member of Institut Universitaire de France
- 10H05: “Innate immunity and inflammation as a metanarrative of medicine, from cancer to Covid-19”
- Alberto MANTOVANI, M.D., Pr., Emeritus Professor of General Pathology and Vice Rector for research at Humanitas University. President of Fondazione Humanitas per la Ricerca
- 10H45: COFFEE BREAK + Posters
Innovative technologies to discover – derisk & accelerate
- 11H05: Centre d’Immunologie Marseille-Luminy (CIML)
- Rafael J ARGÜELLO, PhD, CNRS Researcher
- 11H25: Deeptope
- Raphael SIEROCKI, PhD, Deeptope President
- 11H45: MI-mAbs
- François ROMAGNE, Pr., Professor in immuno-technologies, Mi-mAbs Scientific Director
- 12H05: Sponsor
- 12H10: LUNCH + Posters
Derisk & optimize clinical trials in immune-based therapies
- 13H40: IHU – Méditerranée Infection
- Pierre-Edouard FOURNIER, Pr., IHU – Méditerranée Infection Director
- 14H00: Novadiscovery
- Alexander KULESZA, PhD,Team leader Modeling & simulation / Biomodeling
- 14H20: INRIA-COMputational Pharmacology in Oncology (COMPO)
- Joseph CICCOLINI, Pr., Professor of Pharmacokinetics, Clinical Pharmacologist (PU-PH)
- 14H40: Sponsor
- 14H45: COFFEE BREAK + Posters
New treatment opportunities at clinical stage
- 15H05: ImCheck Therapeutics speaker to be confirmed
- 15H25: Sanofi
- Angélique BIANCOTTO, PhD, Sr Principal Scientist, Flow group head, Precision Oncology speaker to be confirmed
- 15H45: Servier
- Jeanne ALLINNE, PhD, Head of Immuno-Inflammation Research
- 16H05: Eurobiomed Closing
- Emilie ROYERE, Executive Director
|
|
